Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Argenx, Ascentage, Astellas, Astrazeneca, Ausper, Ausperbio, Drug Farm, Harbour, Iaso, Innovent, Invivyd, Kazia, Moderna, Recce, Sihuan, Skyline, Specialised, Transcenta, Xuanzhu, Zai Lab.
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Aimed, Alvotech, Amgen, Beigene, Biocon, Biocytogen, Boehringer Ingelheim, Celltrion, Chime, Coherus, Edirna, Fresenius Kabi, Fresenius SE, Genequantum, Hong-Kong King Friend Industry, Huadong Medicine, Innovent, Leaderna, Leads, Lipigon, Meitheal, Organon, Pheon, Remegen, Samsung Bioepis, Sandoz, Sanyou, Shionogi, Sirnaomics, SK Bioscience, Xentria, Zymedi.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Accurkardia, Spark Biomedical, Tandem Diabetes Care.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Accustem, Arkray, Coagusense, GI Dynamics, Hyperfine, Illumina, Labcorp, Medgenome, Morphic Medical, Nanostring Technologies, Owlet, Pixium, Radon Medical, Tristate Biomedical, Rockwell Medical.